卵巢癌病人腹腔内治疗的应用已日益引起注意。药理学研究证明经腹腔给药有明显疗效。因此发展一种安全有效的方法以提供长期的腹腔通道相当重要。本文报道作者应用一种可注药作腹腔内治疗的注射门及导管系统的初步经验。 Post-A-Cath腹腔导管系统由一连接腹腔导管的皮下注射门构成。在锁骨中线外侧肋缘之上造 The application of intraperitoneal treatment of ovarian cancer patients has drawn increasing attention. Pharmacological studies have shown that there are significant effects of intraperitoneal administration. Therefore, developing a safe and effective way to provide long-term abdominal access is very important. This article reports the authors’ first experience with an injectable gate and catheter system that can be injected intraperitoneally. The Post-A-Cath peritoneal catheter system consists of a subcutaneous injection portal connected to the abdominal duct. In the middle of the clavicle medial ribs on the edge of the building